Impact of l-carnitine on levels of myocardial damage and inflammation biomarkers after percutaneous coronary interventio
Not Applicable
- Conditions
- ischemic heart disease.Myocardial ischemia followed by decreased oxygen to the myocardiumI20-I25
- Registration Number
- IRCT201302088698N10
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with ischemic heart disease that have more than 50 percent occlusion in angiography findings and candidates for elective Pecrcutaneous Coronary Intevention.Exclusion criteria: cardiogenic shock;ST Elevation Myocardial Infarction;pregnant and lactating womens;patients under 18 years;immunologic or hematologic disorders;current infection;chronic kidney disease;serum creatinine above 2.5 mg/dl;hypothyroidism;epilepsy or convulsion;chronic liver disease;cancer
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method High sensitive C--Reactive protein. Timepoint: baseline¸24 and 48 hours after. Method of measurement: Elisa kit.;Troponin I. Timepoint: baseline¸24 and 48 hours after. Method of measurement: Elisa kit.
- Secondary Outcome Measures
Name Time Method